Macrophage Yap is upregulated in both patients and mouse atherosclerotic lesions, and myeloid-specific overexpression of Yap in mice promoted the development of atherosclerosis, suggesting that interfering of Yap activation could be a therapeutic opportunity for atherosclerosis (Liu et al., 2020). The gene discussed is YAP1; the disease is atherosclerosis.